Michel D. Kazatchkine

Surface-associated heparin inhibits zymosan-induced activation of the human alternative complement pathway by augmenting the regulatory action of the control proteins on particle-bound C3b

M. Kazatchkine, D. Fearon, K. Austen, 1979, The Journal of experimental medicine.

Structure-function relationships in the inhibitory effect of heparin on complement activation: independency of the anti-coagulant and anti-complementary sites on the heparin molecule.

M. Kazatchkine, M. Petitou, J. Choay, 1988, Molecular immunology.

Relative inefficiency of terminal complement activation.

M. Kazatchkine, S. Bhakdi, P. Malasit, 1988, Journal of immunology.

Double‐blind placebo‐controlled trial of oral dehydroepiandrosterone in patients with advanced HIV disease

A. Leplège, M. Kazatchkine, B. Debuire, 2001, Clinical endocrinology.